| Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
| Veids | Citi |
| Valoda | EN |
| Statuss | Publicēts |
| Versija | |
| Datums | 2011-08-19 18:26:04 |
| Versijas komentārs | |
| Teksts |
Olaine, August 19, 2011
„Olainfarm” wins in „MIDOLAT/МИДОЛАТ”
dispute
District court of Riga today rejected the claim by AS
"Grindeks" whereby the nullification of the registration of trade
mark „MIDOLAT/МИДОЛАТ” was asked. Therefore AS „Olainfarm” is now
free to use the name „MIDOLAT/МИДОЛАТ” in Latvia.
On July 20, 2010, „Grindeks” submitted a claim to court
asking to nullify the registration of trade mark
MIDOLAT/МИДОЛАТ (in Cyrillic), to discontinue and
forbid the use of the textual designations MIDOLAT/МИДОЛАТ by
„Olainfarm”, to fully recall from distribution and to destroy all
medicines market with textual designations MIDOLAT/МИДОЛАТ.
„Olainfarm” was accused of acting in an illegal manner to
crease associations with trademarks owned by „Grindeks”. On
March 14, an additional claim was submitted to court asking
“Olainfarm” to compensate for the damages.
On August 19 2011, a District court of Riga ruled that
all these claims are unfounded and rejected them. Latvia is
now the second country where this desperate attempt made by
“Grindeks” to block the launch of meldonium produced by “Olainfarm”
has failed. Although in the interests of “Grindeks” it managed
to delay the launch a little, the main party suffering were the
patients. In the near future similar claims by “Grindex” against
“Rospatent” are scheduled in Moscow.
During the court trial „Olainfarm” submitted the
counterclaim about nullification of registration of trademark
“Mildronāts”. Counterclaim of “Olainfarm” is founded on the fact
that a word “mildronāts” has been historically used and is still
being used in an everyday communication as the name for particular
medicine and therefore cannot be registered as the trade mark.
Although Olainfarm’s counter claim was rejected for the lack of
evidence, Olainfarm regards its position as strong enough to appeal
against this ruling of District court of Riga to Supreme
Court.
It was not Olainfarm’s choice to start the legal
procedure and during the entire process we made a number of
attempts to prevent this conflict from further escalation, we have
expressed our willingness to negotiate and solve the dispute out of
court.
„I am very satisfied with this just
ruling. Olainfarm has always been acting fairly and honestly
respecting ourselves, our partners and competitors. We see the
development of new and effective products as our main priority,
therefore despite favourable verdict and good prospects for further
appeals, we would prefer solving similar situations without
unnecessary waste of time in courts,” said V. Maligins, Chairman of
Olainfarm’s Management Board.
A/s Olainfarm is one of the biggest pharmaceutical
companies in Latvia with nearly 40 years of experience in
production of medication and chemical and pharmaceutical products.
A basic principle of company's operations is to produce reliable
and effective top quality products for Latvia and the rest of the
world. Products made by the Group are being exported to more than
30 countries of the world, including the Baltics, Russia, other
CIS, Europe, Asia, North America and Australia.
Information
prepared by:
Salvis Lapins Member of the Board A/s „Olainfarm” Tel: +371 6 7013 717 Cell: +371 2 6448 873 E-mail: slapinsh@olainfarm |
| Pielikumi |
|